Annual Shareholders Equity
-$346.30 M
-$998.67 M-153.08%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual stockholders equity is -$346.30 million, with the most recent change of -$998.67 million (-153.08%) on December 31, 2023.
- During the last 3 years, IRWD annual shareholders equity has fallen by -$408.94 million (-652.83%).
- IRWD annual shareholders equity is now -153.08% below its all-time high of $652.38 million, reached on December 31, 2022.
Performance
IRWD Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$311.33 M
+$10.39 M+3.23%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly stockholders equity is -$311.33 million, with the most recent change of +$10.39 million (+3.23%) on September 30, 2024.
- Over the past year, IRWD quarterly shareholders equity has stayed the same.
- IRWD quarterly shareholders equity is now -144.05% below its all-time high of $706.85 million, reached on March 31, 2023.
Performance
IRWD Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
IRWD Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -153.1% | 0.0% |
| 3 y3 years | -652.8% | -151.4% |
| 5 y5 years | -76.3% | -151.4% |
IRWD Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -153.1% | at low | -144.1% | +10.1% |
| 5 y | 5-year | -153.1% | at low | -144.1% | +10.1% |
| alltime | all time | -153.1% | at low | -144.1% | +10.1% |
Ironwood Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$311.33 M(-3.2%) |
| Jun 2024 | - | -$321.73 M(-2.7%) |
| Mar 2024 | - | -$330.52 M(-4.6%) |
| Dec 2023 | -$346.30 M(-153.1%) | -$346.30 M(+7.1%) |
| Sep 2023 | - | -$323.22 M(-6.5%) |
| Jun 2023 | - | -$345.70 M(-148.9%) |
| Mar 2023 | - | $706.85 M(+8.4%) |
| Dec 2022 | $652.38 M(+7.7%) | $652.38 M(+10.4%) |
| Sep 2022 | - | $591.06 M(+10.9%) |
| Jun 2022 | - | $532.88 M(+2.9%) |
| Mar 2022 | - | $517.78 M(-14.5%) |
| Dec 2021 | $605.91 M(+867.3%) | $605.91 M(+4.5%) |
| Sep 2021 | - | $579.94 M(+13.3%) |
| Jun 2021 | - | $511.76 M(+364.4%) |
| Mar 2021 | - | $110.19 M(+75.9%) |
| Dec 2020 | $62.64 M(-167.2%) | $62.64 M(+961.0%) |
| Sep 2020 | - | $5.90 M(-116.0%) |
| Jun 2020 | - | -$36.85 M(-48.5%) |
| Mar 2020 | - | -$71.56 M(-23.3%) |
| Dec 2019 | -$93.25 M(-52.5%) | -$93.25 M(-39.1%) |
| Sep 2019 | - | -$153.05 M(-30.2%) |
| Jun 2019 | - | -$219.37 M(-7.5%) |
| Mar 2019 | - | -$237.18 M(+20.8%) |
| Dec 2018 | -$196.37 M(-2094.0%) | -$196.37 M(-0.5%) |
| Sep 2018 | - | -$197.29 M(+348.9%) |
| Jun 2018 | - | -$43.95 M(+143.5%) |
| Mar 2018 | - | -$18.05 M(-283.3%) |
| Dec 2017 | $9.85 M(-85.2%) | $9.85 M(-156.0%) |
| Sep 2017 | - | -$17.58 M(-461.0%) |
| Jun 2017 | - | $4.87 M(-83.6%) |
| Mar 2017 | - | $29.64 M(-55.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $66.72 M(-29.9%) | $66.72 M(+12.2%) |
| Sep 2016 | - | $59.46 M(-26.9%) |
| Jun 2016 | - | $81.38 M(-10.5%) |
| Mar 2016 | - | $90.94 M(-4.4%) |
| Dec 2015 | $95.13 M(+7.4%) | $95.13 M(-5.3%) |
| Sep 2015 | - | $100.46 M(-28.4%) |
| Jun 2015 | - | $140.28 M(+105.8%) |
| Mar 2015 | - | $68.16 M(-23.0%) |
| Dec 2014 | $88.55 M(+131.7%) | $88.55 M(-18.1%) |
| Sep 2014 | - | $108.15 M(-23.7%) |
| Jun 2014 | - | $141.83 M(-24.9%) |
| Mar 2014 | - | $188.94 M(+394.3%) |
| Dec 2013 | $38.23 M(-73.5%) | $38.23 M(-54.6%) |
| Sep 2013 | - | $84.21 M(-39.6%) |
| Jun 2013 | - | $139.42 M(+138.2%) |
| Mar 2013 | - | $58.52 M(-59.4%) |
| Dec 2012 | $144.05 M(+31.1%) | $144.05 M(-20.9%) |
| Sep 2012 | - | $182.11 M(+41.4%) |
| Jun 2012 | - | $128.78 M(-21.5%) |
| Mar 2012 | - | $164.15 M(+49.4%) |
| Dec 2011 | $109.86 M(-31.1%) | $109.86 M(-2.7%) |
| Sep 2011 | - | $112.93 M(-13.2%) |
| Jun 2011 | - | $130.12 M(-10.0%) |
| Mar 2011 | - | $144.59 M(-9.4%) |
| Dec 2010 | $159.55 M(-152.9%) | $159.55 M(-6.6%) |
| Jun 2010 | - | $170.74 M(-8.2%) |
| Mar 2010 | - | $185.92 M(-161.7%) |
| Dec 2009 | -$301.55 M(+27.9%) | -$301.55 M(-1658.3%) |
| Sep 2009 | - | $19.35 M(-108.2%) |
| Dec 2008 | -$235.75 M(+27.5%) | -$235.75 M |
| Dec 2007 | -$184.87 M | - |
FAQ
- What is Ironwood Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual shareholders equity year-on-year change?
- What is Ironwood Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Ironwood Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of IRWD is -$346.30 M
What is the all time high annual shareholders equity for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual stockholders equity is $652.38 M
What is Ironwood Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, IRWD annual stockholders equity has changed by -$998.67 M (-153.08%)
What is Ironwood Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of IRWD is -$311.33 M
What is the all time high quarterly shareholders equity for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly stockholders equity is $706.85 M
What is Ironwood Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, IRWD quarterly stockholders equity has changed by $0.00 (0.00%)